JP2012518659A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518659A5
JP2012518659A5 JP2011551313A JP2011551313A JP2012518659A5 JP 2012518659 A5 JP2012518659 A5 JP 2012518659A5 JP 2011551313 A JP2011551313 A JP 2011551313A JP 2011551313 A JP2011551313 A JP 2011551313A JP 2012518659 A5 JP2012518659 A5 JP 2012518659A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
compound
lysine
amino acid
basic amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551313A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012518659A (ja
JP5779106B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/025252 external-priority patent/WO2010099213A1/en
Publication of JP2012518659A publication Critical patent/JP2012518659A/ja
Publication of JP2012518659A5 publication Critical patent/JP2012518659A5/ja
Application granted granted Critical
Publication of JP5779106B2 publication Critical patent/JP5779106B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551313A 2009-02-24 2010-02-24 抗腫瘍剤としての4−ヒドロペルオキシイホスファミドの錯体 Expired - Fee Related JP5779106B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15507209P 2009-02-24 2009-02-24
US61/155,072 2009-02-24
PCT/US2010/025252 WO2010099213A1 (en) 2009-02-24 2010-02-24 Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents

Publications (3)

Publication Number Publication Date
JP2012518659A JP2012518659A (ja) 2012-08-16
JP2012518659A5 true JP2012518659A5 (cg-RX-API-DMAC7.html) 2013-02-21
JP5779106B2 JP5779106B2 (ja) 2015-09-16

Family

ID=42111918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551313A Expired - Fee Related JP5779106B2 (ja) 2009-02-24 2010-02-24 抗腫瘍剤としての4−ヒドロペルオキシイホスファミドの錯体

Country Status (6)

Country Link
US (1) US8361992B2 (cg-RX-API-DMAC7.html)
EP (1) EP2401285B1 (cg-RX-API-DMAC7.html)
JP (1) JP5779106B2 (cg-RX-API-DMAC7.html)
AU (1) AU2010218109B2 (cg-RX-API-DMAC7.html)
CA (1) CA2753041A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010099213A1 (cg-RX-API-DMAC7.html)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5230519B2 (cg-RX-API-DMAC7.html) 1972-04-05 1977-08-09
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
ES2040394T3 (es) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft Procedimiento para preparar un material liofilizado de ifosfamida y mesna.
WO1993021173A1 (en) 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
WO2006000422A1 (de) * 2004-06-29 2006-01-05 Baxter International Inc. Verfahren zur herstellung von lagerstabiler mafosfamid-lysin-salz lyophilisat bulkware
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) * 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체

Similar Documents

Publication Publication Date Title
JP5513405B2 (ja) 自己磁性金属サレン錯体化合物
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2022527114A5 (cg-RX-API-DMAC7.html)
JP2013544846A5 (cg-RX-API-DMAC7.html)
JP2019513764A5 (cg-RX-API-DMAC7.html)
JP2016505586A5 (cg-RX-API-DMAC7.html)
JP2014515406A5 (cg-RX-API-DMAC7.html)
JP2020506951A5 (cg-RX-API-DMAC7.html)
JP2019514426A5 (cg-RX-API-DMAC7.html)
CA2653941A1 (en) Substituted amino purine derivatives and uses thereof
JP2011506274A5 (cg-RX-API-DMAC7.html)
JP2012505250A5 (cg-RX-API-DMAC7.html)
JP2015512943A5 (cg-RX-API-DMAC7.html)
JP2017036314A5 (cg-RX-API-DMAC7.html)
JP2014527974A5 (cg-RX-API-DMAC7.html)
JP2012506703A5 (cg-RX-API-DMAC7.html)
JP2014508804A5 (cg-RX-API-DMAC7.html)
JP2021526017A5 (cg-RX-API-DMAC7.html)
JP2018509143A5 (cg-RX-API-DMAC7.html)
JP2008517949A5 (cg-RX-API-DMAC7.html)
JP2018515563A5 (cg-RX-API-DMAC7.html)
JP2012533601A5 (cg-RX-API-DMAC7.html)
JP2013538213A5 (cg-RX-API-DMAC7.html)
Kim et al. Phosphoryl azides as versatile new reaction partners in the Cu-catalyzed three-component couplings
WO2012111380A1 (ja) 自己磁性金属サレン錯体化合物